erythrosine has been researched along with chiniofon in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brancato, R; Burlamacchi, P; Pratesi, R; Vanni, U | 1 |
| Chang, MS; Chiou, GC | 1 |
| Rieber, M; Rieber, MS; Viola-Rhenals, M | 1 |
3 other study(ies) available for erythrosine and chiniofon
| Article | Year |
|---|---|
Tunable lasers in ophthalmology.
Topics: Animals; Coumarins; Fluoresceins; Fundus Oculi; Hydroxyquinolines; Laser Therapy; Lasers; Rabbits; Rhodamines | 1975 |
Prevention of lens protein-induced ocular inflammation with cyclooxygenase and lipoxygenase inhibitors.
Topics: Animals; Crystallins; Cyclooxygenase Inhibitors; Drug Therapy, Combination; Eye Diseases; Female; Fluoresceins; Fluorophotometry; Hydroxyquinolines; Indomethacin; Inflammation; Lipoxygenase Inhibitors; Male; Prednisolone; Quinolines; Rabbits | 1989 |
Suppression of survival in human SKBR3 breast carcinoma in response to metal-chelator complexes is preferential for copper-dithiocarbamate.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Chelating Agents; Copper; Ditiocarb; Fluoresceins; Humans; Hydroxyquinolines; Organometallic Compounds; Oxyquinoline; Zinc | 2006 |